相关实验视频

Updated: Jul 23, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

化学抗原受体T细胞进入T细胞恶性瘤

Jie Tang¹, Xudong Zhao²

¹Department of Targeting Therapy & Immunology and Laboratory of Animal Tumor Models, Cancer Center and National Clinical Research Center for Geriatrics and Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Journal of cancer research and clinical oncology

|July 19, 2023

概括

化学抗原受体 (CAR) T细胞疗法对T细胞恶性瘤有希望,但需要解决抗原共享和制造质量等挑战. 本综述探讨了在这些癌症中有效的CAR-T治疗的当前应用和未来战略.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
血液学血液学血液学

背景情况:

恶性T细胞瘤是具有不良预后和治疗耐药性的侵略性血液癌症.
化学抗原受体 (CAR) T细胞疗法对B细胞恶性瘤非常有效,但对T细胞癌症的研究较少.
目前CAR-T对T细胞恶性瘤的疗效受到制造挑战和瘤特异性的生物因素的限制.

研究的目的:

审查CAR-T疗法在T细胞恶性瘤中的当前临床应用.
确定并提出克服阻碍CAR-T治疗有效性的挑战的策略.
概述未来的路线图,以实施CAR-T疗法作为T细胞癌症的可行治疗选择.

主要方法:

目前临床试验的文献综述和对T细胞恶性瘤的CAR-T疗法的研究.
在T细胞癌症的背景下,分析影响CAR-T细胞制造和功能的因素.
综合现有数据以确定挑战并提出解决方案.

主要成果:

卡特-T疗法已经显示出潜力,但在T细胞恶性瘤中面临重大障碍.
关键的挑战包括抗原表达重叠,制造纯度和点/瘤外毒性.
正在开发新型向抗原选择和改进制造协议等战略.

结论:

卡尔-T细胞疗法对治疗T细胞恶性瘤具有前景.
解决制造质量和生物挑战对于成功的临床实施至关重要.
需要进一步的研究和战略开发,以建立CAR-T作为标准治疗.

关键词:

在CART-T中,使用CART-T.卡特-T产品污染的污染情况杀害兄弟的是一种罪行.由于T细胞无形成.在T细胞恶性瘤中.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...